This inventor holds 1 USPTO granted patent. Top assignee: Olix Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: June Hyun Park and RNAi-Based Therapeutic Innovation.
Introduction
June Hyun Park is an inventor based in Gyeonggi-do, South Korea. His listed patent work concerns an RNA interference (RNAi) agent targeting MYD88 and its use.
Latest Patents
Park is associated with one patent: “RNAi Agent Targeting MYD88 and Use Thereof.” The invention focuses on an RNAi agent directed at MYD88, a target relevant to therapeutic research. The available information does not specify the patent’s filing or grant date. Park’s listed total is 1 patent.
Career Highlights
Park is associated with Olix Pharmaceuticals, Inc., a company working in the biotechnology field. His listed patent reflects involvement in research and development related to RNAi-based approaches.
Collaborations
Park’s listed coworker is Sun Woo Hong, a woman. The available information identifies their professional association but does not describe specific joint projects or contributions.
Conclusion
June Hyun Park’s recorded patent work centers on an RNAi agent targeting MYD88, connecting his inventive activity with therapeutic research at Olix Pharmaceuticals, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile